Can Extracorporeal Shock Wave Therapy Be Effective in Temporomandibular Joint Disease

October 28, 2022 updated by: Serap Keskin Tunc, Yuzuncu Yıl University

Evaluation of the Clinical Efficacy of Extracorporeal Shock Wave Therapy in Temporomandibular Joint Patients Having Disc Displacement With Reduction

The aim of this study is to evaluate the clinical efficacy of Extracorporeal Shock Wave Therapy (ESWT) in patients with Temporomandibular Joint (TMJ) with Reduced Disc Displacement, by comparing it with standard treatment.

Scientific Basis and Validity of Medical Research: Temporomandibular Joint Disorders (TMR) are disorders that can cause pain in the head and neck region, limitation in mouth opening, and difficulties even in daily activities (eating, speaking, chewing, yawning, etc.). These disorders have various causes such as malocclusion, emotional stress, parafunctional habits, synovitis, capsulitis, osteoarthritis and intra-articular irregularities. Almost 25% of the world's population has TMJ intra-articular irregularities and these are usually treated with non-surgical methods. If these methods are not successful, surgical treatments are generally used. These non-surgical treatments include many physical therapy interventions such as occlusal splints, medical treatments, bite plates, ultrasound and subcutaneous electrical nerve stimulation, and low-level laser therapies. With these intraorally used occlusal splints, a balanced occlusal contact is achieved without applying any force to the mandible in the resting position. Occlusal splints are available in different designs and different construction materials. The stabilization splint, which is one of the most commonly used occlusal splints, and the modified Hawley splint are appliances produced from hard materials. However, some researchers have commented that soft spints produced from resilient materials may also be useful in the distribution of excessive force formed in parafunctional habits. While there are studies stating that hard splints provide more successful results than soft splints in the functional problems of the chewing system, there are also studies reporting that they have similar efficacy on muscle pain after short-term use.

Extracorporeal shock wave therapy (ESWT), another physical therapy modality, used in the treatment of various joint and muscle pains; it is an advantageous treatment modality that is non-invasive, well tolerated by patients and has few side effects. This modality is also used in diseases of the TMJ and masticatory muscles in various sources. The availability of different non-standard treatment regimens and the few studies on the short-term results of ESWT applications make the use of ESWT in the treatment of TMJ diseases still unclear and new studies are needed.

Study Overview

Study Type

Interventional

Enrollment (Actual)

80

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Van, Turkey, 65080
        • Beyza Ünalan Değirmenci

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 70 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Diagnosed with reduced disc displacement according to DC/TMD examination criteria
  • 18-70 years old
  • No systemic disease that may have effects on masticatory muscles or TMJ
  • Individuals who do not have any tooth loss other than 3. molar teeth and accept the treatments to be done

Exclusion Criteria:

  • Individuals with total or distal extension partial dentures
  • Individuals who have previously received medical, pharmacological, or any form of treatment for TMD
  • Individuals with recent facial or cervical trauma
  • Individuals with the syndrome who have the potential to affect any component of the stomagnatic system
  • Individuals with parafunctional habits such as clenching or grinding their teeth.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Extracorporeal Shock Wave Therapy
Extracorporeal shock wave therapy (ESWT) is an expedient remedy that is used in various joint and muscle pain treatments, is non-invasive, is well tolerated by patients, and has few side effects.
Extracorporeal shock wave therapy (ESWT) is an expedient remedy that is used in various joint and non-invasive muscle pain treatments

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
VAS pain score
Time Frame: At baseline
A Visual Analogue Scale (VAS) is one of the pain rating scales between 1-10.
At baseline
VAS pain score
Time Frame: 1 week
A Visual Analogue Scale (VAS) is one of the pain rating scales between 1-10.
1 week
VAS pain score
Time Frame: 2 week
A Visual Analogue Scale (VAS) is one of the pain rating scales between 1-10.
2 week
Painless Maximum Active Mouth Opening
Time Frame: At baseline
Measurement with one exception (pain-free opening), every time the patients moves his/her mouth vertically or excursively, he or she is instructed to move it as far as possible in that direction in milimeter.
At baseline
Painless Maximum Active Mouth Opening
Time Frame: 1 week
Measurement with one exception (pain-free opening), every time the patients moves his/her mouth vertically or excursively, he or she is instructed to move it as far as possible in that direction in milimeter.
1 week
Painless Maximum Active Mouth Opening
Time Frame: 2 week
Measurement with one exception (pain-free opening), every time the patients moves his/her mouth vertically or excursively, he or she is instructed to move it as far as possible in that direction in milimeter.
2 week
Passive Forced Mouth Opening
Time Frame: At baseline
Measurement of movements for range of motion and for joint sounds are made with actively pushed on by the examiner in milimeter.
At baseline
Passive Forced Mouth Opening
Time Frame: 1 week
Measurement of movements for range of motion and for joint sounds are made with actively pushed on by the examiner in milimeter.
1 week
Passive Forced Mouth Opening
Time Frame: 2 week
Measurement of movements for range of motion and for joint sounds are made with actively pushed on by the examiner in milimeter.
2 week

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2020

Primary Completion (Actual)

January 30, 2021

Study Completion (Actual)

February 1, 2021

Study Registration Dates

First Submitted

October 20, 2022

First Submitted That Met QC Criteria

October 28, 2022

First Posted (Actual)

October 31, 2022

Study Record Updates

Last Update Posted (Actual)

October 31, 2022

Last Update Submitted That Met QC Criteria

October 28, 2022

Last Verified

October 1, 2022

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 29.01.2020/14

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Temporomandibular Joint Disc Displacement, With Reduction

Clinical Trials on Extracorporeal Shock Wave Therapy

Subscribe